Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 11;7(1):11174.
doi: 10.1038/s41598-017-10724-0.

In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences

Affiliations

In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences

Zhengwei Li et al. Sci Rep. .

Abstract

Analysis of drug-target interactions (DTIs) is of great importance in developing new drug candidates for known protein targets or discovering new targets for old drugs. However, the experimental approaches for identifying DTIs are expensive, laborious and challenging. In this study, we report a novel computational method for predicting DTIs using the highly discriminative information of drug-target interactions and our newly developed discriminative vector machine (DVM) classifier. More specifically, each target protein sequence is transformed as the position-specific scoring matrix (PSSM), in which the evolutionary information is retained; then the local binary pattern (LBP) operator is used to calculate the LBP histogram descriptor. For a drug molecule, a novel fingerprint representation is utilized to describe its chemical structure information representing existence of certain functional groups or fragments. When applying the proposed method to the four datasets (Enzyme, GPCR, Ion Channel and Nuclear Receptor) for predicting DTIs, we obtained good average accuracies of 93.16%, 89.37%, 91.73% and 92.22%, respectively. Furthermore, we compared the performance of the proposed model with that of the state-of-the-art SVM model and other previous methods. The achieved results demonstrate that our method is effective and robust and can be taken as a useful tool for predicting DTIs.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
ROC curves by our method on the Enzyme dataset.
Figure 2
Figure 2
ROC curves by our method on the GPCR dataset.
Figure 3
Figure 3
ROC curves by our method on the Icon Channel dataset.
Figure 4
Figure 4
ROC curves by our method on the Nuclear Receptor dataset.
Figure 5
Figure 5
Comparison of ROC curves between DVM and SVM on the Enzyme dataset.
Figure 6
Figure 6
Comparison of ROC curves between DVM and SVM on the GPCR dataset.
Figure 7
Figure 7
Comparison of ROC curves between DVM and SVM on the Ion Channel dataset.
Figure 8
Figure 8
Comparison of ROC curves between DVM and SVM on the Nuclear Receptor dataset.
Figure 9
Figure 9
Flow chart of the proposed method.

References

    1. Brouwers L, Iskar M, Zeller G, van Noort V, Bork P. Network neighbors of drug targets contribute to drug side-effect similarity. PloS one. 2011;6:1–7. doi: 10.1371/journal.pone.0022187. - DOI - PMC - PubMed
    1. Wang D, Wilfred F, Chai Z. Recent advances in computational actinoid chemistry. Chemical Society Reviews. 2012;41.17:5836–5865. doi: 10.1039/c2cs15354h. - DOI - PubMed
    1. Gunther S, et al. SuperTarget and Matador: resources for exploring drug-target relationships. Nucleic Acids Res. 2008;36:919–922. doi: 10.1093/nar/gkm862. - DOI - PMC - PubMed
    1. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012;40:109–114. doi: 10.1093/nar/gkr988. - DOI - PMC - PubMed
    1. Chen X, Ji ZL, Chen YZ. TTD: therapeutic target database. Nucleic Acids Res. 2002;30:412–415. doi: 10.1093/nar/30.1.412. - DOI - PMC - PubMed

Publication types

MeSH terms